Jump to content

Aspirin/meprobamate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 71.191.62.196 (talk) at 22:59, 15 July 2020. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Aspirin/meprobamate
Combination of
AspirinNSAID
MeprobamateAnxiolytic
Clinical data
Trade namesEquagesic
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
Oral
ATC code
Legal status
Legal status

Aspirin/meprobamate (trade name Equagesic /ˌɛkwəˈzɪk/) is a combination drug indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache.

Combinations

There also appears to be a combination with ethoheptazine, an opioid analgesic.[1]

Problems

Equagesic was discontinued in the United States, possibly because of its toxic profile and more adequate drugs available. Specifically, meprobamate is more toxic than benzodiazepines, which are also useful as a muscle relaxant.

References